BETAGAN is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Levobunolol Hydrochloride.
| Product ID | 0023-4385_21d89a13-52ed-4d3b-82ff-9ef2d8f34900 | 
| NDC | 0023-4385 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | BETAGAN | 
| Generic Name | Levobunolol Hydrochloride | 
| Dosage Form | Solution/ Drops | 
| Route of Administration | OPHTHALMIC | 
| Marketing Start Date | 1986-07-24 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA019219 | 
| Labeler Name | Allergan, Inc. | 
| Substance Name | LEVOBUNOLOL HYDROCHLORIDE | 
| Active Ingredient Strength | 5 mg/mL | 
| Pharm Classes | Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Category | NDA | 
| Application Number | NDA019219 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 1986-07-24 | 
| Marketing End Date | 2019-01-30 | 
| Marketing Category | NDA | 
| Application Number | NDA019219 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 1986-07-24 | 
| Marketing End Date | 2018-01-30 | 
| Marketing Category | NDA | 
| Application Number | NDA019219 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 1986-07-24 | 
| Marketing End Date | 2019-02-01 | 
| Ingredient | Strength | 
|---|---|
| LEVOBUNOLOL HYDROCHLORIDE | 5 mg/mL | 
| SPL SET ID: | 1a32c0e8-7d10-447e-a7c4-252c98b629bd | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0023-4385 | BETAGAN | levobunolol hydrochloride | 
| 24208-505 | Levobunolol Hydrochloride | Levobunolol Hydrochloride | 
| 60758-060 | LEVOBUNOLOL HYDROCHLORIDE | levobunolol hydrochloride | 
| 60758-063 | LEVOBUNOLOL HYDROCHLORIDE | levobunolol hydrochloride | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  BETAGAN  73472939  1327938 Live/Registered | Allergan Pharmaceuticals, Inc. 1984-03-26 |